What anesthesia approach is recommended for patients with myotonic dystrophy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic Management for Myotonic Dystrophy

Use total intravenous anesthesia (TIVA) with propofol and short-acting opioids (remifentanil or fentanyl), avoid succinylcholine completely, and use volatile anesthetics with extreme caution or not at all. 1, 2

Critical Drug Contraindications and Cautions

Absolute Contraindication: Succinylcholine

  • Succinylcholine is contraindicated due to risk of acute rhabdomyolysis, massive potassium release, and hyperkalemic cardiac arrest, similar to Duchenne muscular dystrophy 1
  • Cardiac arrest can occur immediately after injection, even in previously undiagnosed cases 1

Volatile Anesthetics: Use with Extreme Caution

  • While patients with myotonic dystrophy type 2 (DM2) tolerated volatile anesthetics without obvious complications in one series 3, the safer approach is to avoid them given the risk profile similar to other muscular dystrophies 4, 1
  • If volatile agents must be used, prepare the anesthetic workstation by removing vaporizers, changing breathing circuits, and flushing with oxygen at maximum flow 4
  • Maintain trigger-free anesthesia whenever possible to minimize risk 4

Recommended Anesthetic Technique

Primary Approach: Total Intravenous Anesthesia (TIVA)

  • Induction and maintenance with propofol infusion plus remifentanil or fentanyl is the safest documented approach 1, 5, 2
  • Multiple case series demonstrate smooth, quick recovery with this combination without respiratory complications 2
  • One case report successfully used propofol, remifentanil, and rocuronium with epidural anesthesia, achieving fast recovery without respiratory depression or muscle spasm 5

Muscle Relaxation Strategy

  • Non-depolarizing agents (rocuronium, atracurium) can be used cautiously with careful neuromuscular monitoring 1, 5, 2
  • Use minimal dosing: start with 5 mg rocuronium and titrate while monitoring train-of-four (TOF) ratio continuously 5
  • Expect normal response to non-depolarizing relaxants and neostigmine in DM2 patients 3
  • Recovery of TOF ratio to 80% may take 90 minutes; avoid supplemental doses if surgery permits 5

Regional Anesthesia Consideration

  • Regional or local anesthesia is preferred when feasible to avoid general anesthesia complications entirely 4, 6
  • Combined epidural-general anesthesia has been used successfully, reducing opioid and anesthetic requirements 5, 7

Essential Perioperative Monitoring

Respiratory Monitoring

  • Continuous SpO₂ monitoring intraoperatively and for minimum 24 hours postoperatively 1, 8
  • Monitor blood or end-tidal CO₂ levels continuously during the procedure 4, 1
  • Use supplemental oxygen cautiously as it can mask hypoventilation 1, 8

Neuromuscular Monitoring

  • Continuous train-of-four monitoring is mandatory when using muscle relaxants 5
  • Watch for prolonged effects of neuromuscular blockers despite normal responses 5

Critical Preoperative Assessment

Pulmonary Evaluation

  • Measure forced vital capacity (FVC), maximum inspiratory pressure (MIP), maximum expiratory pressure (MEP), and peak cough flow (PCF) 1
  • Patients with FVC <50% predicted require assisted ventilation during all phases of anesthesia 1
  • Consider preoperative training in noninvasive positive pressure ventilation (NPPV) for high-risk patients 4

Cardiac Evaluation

  • Mandatory cardiology consultation before any anesthetic as myotonic dystrophy causes cardiomyopathy and conduction abnormalities 1, 7
  • Assess for autonomic dysfunction-related cardiac abnormalities 8

Postoperative Management and Disposition

Monitoring Duration

  • Continue SpO₂ monitoring for at least 24 hours postoperatively 1, 8
  • Have ICU bed available for postoperative care, especially for patients with FVC <50% predicted 1
  • Delayed respiratory or neurological complications can occur up to 24-48 hours postoperatively 8

Respiratory Support

  • Patients with baseline FVC <50% should continue NPPV postoperatively 1
  • Despite one case report of same-day discharge after robotic hysterectomy 6, this should not be routine practice given the high risk of delayed complications

Common Pitfalls to Avoid

  • Do not use shivering or hypothermia prevention carelessly: mechanical or electrical stimulation can precipitate myotonia that is difficult to abolish 6
  • Avoid excessive sedation: patients show extreme sensitivity to sedatives, opioids, and anesthetic agents 6
  • Do not assume DM2 is identical to DM1: while DM2 patients showed normal responses to standard anesthetics in one series 3, err on the side of caution and follow DM1 precautions
  • Never discharge early without extended monitoring: postoperative respiratory depression is a major risk even with smooth initial recovery 2, 6

References

Guideline

Anesthetic Management for Tendon Lengthening in Duchenne Muscular Dystrophy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anesthesia and myotonic dystrophy type 2: a case series.

Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anesthetic Management for Syringomyelia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.